The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVV.L Regulatory News (AVV)

  • There is currently no data for AVV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - AVEVA GROUP PLC

17 Jan 2023 13:23

RNS Number : 0164N
Barclays PLC
17 January 2023
 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

 

Barclays PLC.

(b)

Owner or controller of interest and short

 

 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

AVEVA GROUP PLC

 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

 

 

offeror/offeree, state this and specify identity of

 

offeror/offeree:

(e)

Date position held/dealing undertaken:

16 Jan 2023

(f)

In addition to the company in 1(c) above, is the discloser making

NO

 

 

 

disclosures in respect of any other party to the offer?

 

 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

 

 

to which the disclosure relates following the dealing(if any)

 

Class of relevant security:

3 5/9p ordinary

 

Interests

Short Positions

 

Number

(%)

Number

(%)

(1)

Relevant securities owned

 

 

 

 

 

and/or controlled:

 

 

1,978,126

0.65%

1,501,556

0.50%

(2)

Cash-settled derivatives:

 

 

 

 

 

and/or controlled:

 

 

1,565,888

0.52%

1,554,660

0.51%

(3)

Stock-settled derivatives (including options)

 

 

 

 

 

and agreements to purchase/sell:

 

 

0

0.00%

0

0.00%

 

 

 

 

 

 

 

 

 

TOTAL:

 

 

3,544,014

1.17%

3,056,216

1.01%

(b)

Rights to subscribe for new securities (including directors and other executive

 

 

options)

 

 

 

 

 

 

Class of relevant security in relation to

 

 

 

 

which subscription right exists

 

 

 

 

Details, including nature of the rights

 

 

 

 

concerned and relevant percentages:

 

 

 

 

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

 

 

 

 

 

Class of relevant

Purchase/sale

Number of

Price per unit

security

 

securities

 

3 5/9p ordinary

Purchase

16

32.1968 GBP

3 5/9p ordinary

Purchase

54

32.1950 GBP

3 5/9p ordinary

Purchase

78

32.1982 GBP

3 5/9p ordinary

Purchase

197

32.2050 GBP

3 5/9p ordinary

Purchase

266

32.1850 GBP

3 5/9p ordinary

Purchase

673

32.2100 GBP

3 5/9p ordinary

Purchase

1,220

32.2066 GBP

3 5/9p ordinary

Purchase

2,221

32.2000 GBP

3 5/9p ordinary

Purchase

3,867

32.1807 GBP

3 5/9p ordinary

Purchase

4,000

32.2072 GBP

3 5/9p ordinary

Purchase

7,452

32.1975 GBP

3 5/9p ordinary

Purchase

8,285

32.1984 GBP

3 5/9p ordinary

Purchase

9,698

32.2010 GBP

3 5/9p ordinary

Purchase

11,205

32.1883 GBP

3 5/9p ordinary

Purchase

19,171

32.1900 GBP

3 5/9p ordinary

Purchase

40,059

32.1963 GBP

3 5/9p ordinary

Purchase

73,184

32.1854 GBP

3 5/9p ordinary

Sale

20

32.1846 GBP

3 5/9p ordinary

Sale

79

32.1891 GBP

3 5/9p ordinary

Sale

124

32.1962 GBP

3 5/9p ordinary

Sale

174

32.1985 GBP

3 5/9p ordinary

Sale

188

32.1917 GBP

3 5/9p ordinary

Sale

199

32.1840 GBP

3 5/9p ordinary

Sale

210

32.1850 GBP

3 5/9p ordinary

Sale

251

32.2025 GBP

3 5/9p ordinary

Sale

286

32.1988 GBP

3 5/9p ordinary

Sale

366

32.1948 GBP

3 5/9p ordinary

Sale

495

32.2067 GBP

3 5/9p ordinary

Sale

673

32.2100 GBP

3 5/9p ordinary

Sale

787

32.1905 GBP

3 5/9p ordinary

Sale

926

32.1981 GBP

3 5/9p ordinary

Sale

974

32.2050 GBP

3 5/9p ordinary

Sale

1,202

32.1919 GBP

3 5/9p ordinary

Sale

1,288

32.1986 GBP

3 5/9p ordinary

Sale

1,302

32.2008 GBP

3 5/9p ordinary

Sale

1,359

32.2015 GBP

3 5/9p ordinary

Sale

1,517

32.2001 GBP

3 5/9p ordinary

Sale

4,310

32.2000 GBP

3 5/9p ordinary

Sale

4,831

32.1897 GBP

3 5/9p ordinary

Sale

5,036

32.1873 GBP

3 5/9p ordinary

Sale

5,185

32.1944 GBP

3 5/9p ordinary

Sale

11,125

32.1937 GBP

3 5/9p ordinary

Sale

13,569

32.1900 GBP

3 5/9p ordinary

Sale

57,543

32.1875 GBP

 

 

 

 

 

 

 

 

(b)

Cash-settled derivative transactions

 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

 

reference

unit

security

 

 

securities

 

3 5/9p ordinary

CFD

Long

1

32.1900 GBP

3 5/9p ordinary

CFD

Long

20

32.1845 GBP

3 5/9p ordinary

SWAP

Long

27

32.2001 GBP

3 5/9p ordinary

SWAP

Long

36

32.1998 GBP

3 5/9p ordinary

CFD

Long

72

32.1873 GBP

3 5/9p ordinary

SWAP

Long

79

32.1890 GBP

3 5/9p ordinary

SWAP

Long

188

32.1917 GBP

3 5/9p ordinary

SWAP

Long

199

32.1840 GBP

3 5/9p ordinary

SWAP

Long

251

32.2025 GBP

3 5/9p ordinary

SWAP

Long

269

32.2100 GBP

3 5/9p ordinary

SWAP

Long

495

32.2067 GBP

3 5/9p ordinary

SWAP

Long

1,202

32.1919 GBP

3 5/9p ordinary

CFD

Long

2,174

32.1837 GBP

3 5/9p ordinary

SWAP

Long

5,555

32.1952 GBP

3 5/9p ordinary

SWAP

Short

38

32.2100 GBP

3 5/9p ordinary

SWAP

Short

54

32.1950 GBP

3 5/9p ordinary

SWAP

Short

56

32.1866 GBP

3 5/9p ordinary

CFD

Short

72

32.2126 GBP

3 5/9p ordinary

SWAP

Short

132

32.1891 GBP

3 5/9p ordinary

SWAP

Short

143

32.2014 GBP

3 5/9p ordinary

SWAP

Short

187

32.1900 GBP

3 5/9p ordinary

SWAP

Short

292

32.1927 GBP

3 5/9p ordinary

SWAP

Short

2,213

32.2000 GBP

3 5/9p ordinary

SWAP

Short

3,739

32.1879 GBP

3 5/9p ordinary

SWAP

Short

4,000

32.2072 GBP

3 5/9p ordinary

SWAP

Short

13,845

32.2012 GBP

3 5/9p ordinary

SWAP

Short

17,310

32.1995 GBP

3 5/9p ordinary

SWAP

Short

33,836

32.1948 GBP

 

 

 

 

 

 

 

 

(c)

Stock-settled derivative transactions (including options)

 

(i)

Writing, selling, purchasing or varying

 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

 

date

money

relevant

 

selling,

securities

per unit

 

 

paid/

security

 

varying etc

to which

 

 

 

received

 

 

 

option

 

 

 

per unit

 

 

 

relates

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(ii)

Exercising

 

 

 

 

 

 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

 

 

securities

unit

 

 

 

 

 

 

 

 

 

 

 

 

 

(d)

Other dealings (including subscribing for new securities)

 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

 

 

applicable)

 

 

 

 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,

 

 

formal or informal, relating to relevant securities which may be an inducement to deal

 

 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

 

to the offer or any person acting in concert with a party to the offer:

 

 

 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between

 

 

the person making the disclosure and any other person relating to:

 

 

(i) the voting rights of any relevant securities under any option; or

 

 

 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

 

 

any derivative is referenced:

 

 

 

 

 

 

NONE

(c)

Attachments

 

 

 

 

 

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

17 Jan 2023

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETGPUUPGUPWGWM
Date   Source Headline
18th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc
18th Jan 20232:27 pmRNSForm 8.3 - AVEVA Group plc
18th Jan 20231:59 pmRNSForm 8.3 - AVEVA GROUP PLC
18th Jan 20231:11 pmEQSForm 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
18th Jan 202312:02 pmRNSForm 8.5 (EPT/NON-RI)-AVEVA Group plc Amend
18th Jan 202311:11 amRNSForm 8.5 (EPT/RI) - Aveva Group Plc
18th Jan 202311:00 amRNSSCHEME OF ARRANGEMENT BECOMES EFFECTIVE
18th Jan 20239:58 amRNSForm 8.5 (EPT/NON-RI)-AVEVA Group plc
18th Jan 20239:52 amRNSForm 8.3 - Aveva Group Plc
18th Jan 20239:52 amRNSForm 8.5 (EPT/RI)-AVEVA Group plc
18th Jan 20239:10 amRNSForm 8.5 (EPT/RI)
18th Jan 20237:30 amRNSSuspension- Aveva Group PLC
17th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc
17th Jan 20231:23 pmRNSForm 8.3 - AVEVA GROUP PLC
17th Jan 20231:04 pmRNSForm 8.3 - Aveva Group PLC
17th Jan 202312:28 pmRNSForm 8.3 -AVEVA GROUP PLC
17th Jan 202310:38 amRNSForm 8.5 (EPT/RI) - Aveva Group Plc
17th Jan 202310:33 amRNSISSUE AND ALLOTMENT OF NEW AVEVA SHARES
17th Jan 202310:22 amRNSForm 8.3 - Aveva Group Plc
17th Jan 202310:19 amRNSForm 8.5 (EPT/NON-RI)-AVEVA Group plc
17th Jan 202310:10 amRNSForm 8.5 (EPT/RI)-AVEVA Group plc
16th Jan 20233:28 pmRNSCOURT SANCTION OF SCHEME
16th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc
16th Jan 20231:30 pmEQSForm 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
16th Jan 202311:24 amRNSForm 8.5 (EPT/RI) - Aveva Group Plc
16th Jan 202311:17 amRNSForm 8.3 - AVEVA GROUP PLC
16th Jan 202311:14 amRNSForm 8.3 - Aveva Group Plc
16th Jan 202310:12 amRNSForm 8.5 (EPT/NON-RI)-AVEVA Group plc
16th Jan 202310:05 amRNSForm 8.5 (EPT/RI)-AVEVA Group plc
16th Jan 20238:53 amRNSForm 8.5 (EPT/RI)
13th Jan 20236:12 pmRNSAveva Group
13th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc
13th Jan 20231:33 pmEQSForm 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
13th Jan 202311:20 amRNSForm 8.3 - AVEVA GROUP PLC
13th Jan 202310:26 amRNSForm 8.5 (EPT/RI) - Aveva Group Plc
13th Jan 202310:18 amRNSForm 8.5 (EPT/NON-RI)-AVEVA Group plc
13th Jan 202310:15 amRNSForm 8.5 (EPT/RI)-AVEVA Group plc
13th Jan 20239:01 amRNSForm 8.5 (EPT/RI)
13th Jan 20237:00 amRNSForm 8.3 - AVEVA GROUP PLC Amend
12th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc
12th Jan 20233:06 pmRNSForm 8.3 - AVEVA Group plc
12th Jan 20231:24 pmEQSForm 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
12th Jan 202312:05 pmRNSForm 8.3 - AVEVA GROUP PLC
12th Jan 202311:23 amRNSForm 8.5 (EPT/RI) Aveva Group Plc
12th Jan 202310:28 amBUSForm 8.3 - AVV LN Equity 11-January-23 Decrease in Traded Position Disclosure
12th Jan 202310:23 amRNSForm 8.5 (EPT/NON-RI) - AVEVA Group plc
12th Jan 202310:17 amRNSForm 8.5 (EPT/RI) - AVEVA Group plc
12th Jan 20238:35 amRNSForm 8.5 (EPT/RI)
11th Jan 20236:00 pmRNSAveva Group
11th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.